Investment

How Recent Analyst Moves Are Shaping the AMERISAFE Investment Story


AMERISAFE’s consensus analyst price target has shifted downward from $52 to $50.33, reflecting a modest revision in expectations. This adjustment comes as analysts weigh a mix of sector-specific optimism, such as favorable mark-to-market adjustments, against lingering caution around reserve uncertainty and market conditions. Stay tuned to discover how you can keep informed as analysts continue to refine their outlook on AMERISAFE’s evolving story.

Stay updated as the Fair Value for AMERISAFE shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on AMERISAFE.

Analyst commentary on AMERISAFE has recently centered around updated price targets and tempered expectations for the upcoming quarter, reflecting both optimism and caution regarding the company’s performance and the broader insurance landscape.

🐂 Bullish Takeaways

  • Citizens JMP maintained an Outperform rating on AMERISAFE, signaling ongoing confidence in the company’s execution and operational discipline.

  • The firm sees potential positives for the insurance sector in Q3, including lighter-than-typical catastrophe losses and modest mark to market book value tailwinds. These factors are viewed as supportive for AMERISAFE’s financial stability and underlying growth narrative.

🐻 Bearish Takeaways

  • Citizens JMP did lower its price target on AMERISAFE to $60 from $65, reflecting reservations about upside potential in the current market environment.

  • The analyst highlighted ongoing concerns around casualty loss reserves, with the potential for continued issues in this area being a key focus for cautious observers of AMERISAFE.

  • Uncertainty in the overall pricing environment remains a notable risk, as analysts anticipate that this will be an area of heightened scrutiny in upcoming results.

Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there’s more to the story. Head to the Simply Wall St Community to discover more perspectives or begin writing your own Narrative!

NasdaqGS:AMSF Earnings & Revenue History as at Nov 2025
NasdaqGS:AMSF Earnings & Revenue History as at Nov 2025
  • AMERISAFE, Inc. announced a special cash dividend of $1.00 per share, payable on December 12, 2025, to shareholders of record as of December 5, 2025.

  • From July 23, 2025 to September 30, 2025, the company completed the repurchase of 2,287 shares, representing 0.01% of shares outstanding, for $0.1 million as part of the buyback program announced on July 24, 2025.

  • Between July 1, 2025 and July 23, 2025, AMERISAFE repurchased 28,573 shares, or 0.15% of shares outstanding, for $1.2 million. This concludes the repurchase of 1,774,181 shares since the program began in March 2010.



Source link

Leave a Response